| Literature DB >> 31512285 |
Hidemasa Kawamura1,2, Nobuteru Kubo1,2, Hiro Sato1,2, Yuhei Miyasaka1, Hiroshi Matsui2,3, Kazuto Ito3, Kazuhiro Suzuki2,3, Tatsuya Ohno1,2.
Abstract
Proton and carbon ion radiotherapy for the treatment of prostate cancer is associated with a lower incidence of adverse events than conventional radiotherapy. There are few reports on the quality of life of patients treated with particle therapy, and limited patient-reported outcomes. Analysis of quality of life is important for patients treated with radiotherapy alone or in combination with hormonal therapy, and long-term results, dose fractionation and costs need to be included in the analysis. This information might help both clinical decision-making and selection of appropriate treatments according to the individual needs of patients. This study reviews the literature on the quality of life and outcomes of patients treated with particle therapy, and discusses future directions.Entities:
Keywords: carbon ion radiotherapy; particle therapy; prostate cancer; proton therapy; quality of life
Mesh:
Year: 2019 PMID: 31512285 DOI: 10.1111/iju.14102
Source DB: PubMed Journal: Int J Urol ISSN: 0919-8172 Impact factor: 3.369